Theranexus SA logo

ALTHX - Theranexus SA News Story

€3.45 0.3  8.0%

Last Trade - 21/01/22

Sector
Healthcare
Size
Micro Cap
Market Cap £13.2m
Enterprise Value £6.58m
Revenue £n/a
Position in Universe 737th / 851

BRIEF-Theranexus: FDA Issues Favorable Opinion On Preclinical Development Plan Submitted By Theranexus, BBDF

Thu 19th November, 2020 6:44am
Nov 19 (Reuters) - Theranexus SA  ALTHX.PA :
    * FDA ISSUES A FAVORABLE OPINION ON PRECLINICAL DEVELOPMENT
PLAN
SUBMITTED BY THERANEXUS AND BBDF
    * APPROVING THERANEXUS' PROPOSALS TO CONTINUE PRECLINICAL
DEVELOPMENT OF BBDF-101 PREVIOUSLY INITIATED BY COMPANY

Source text for Eikon:  ID:nACT66199 
Further company coverage:  ALTHX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.